BR1101039A - Composição farmacêutica para doenças renais ou cardiovasculares - Google Patents

Composição farmacêutica para doenças renais ou cardiovasculares

Info

Publication number
BR1101039A
BR1101039A BR1101039-8A BR1101039A BR1101039A BR 1101039 A BR1101039 A BR 1101039A BR 1101039 A BR1101039 A BR 1101039A BR 1101039 A BR1101039 A BR 1101039A
Authority
BR
Brazil
Prior art keywords
kidney
pharmaceutical composition
cardiovascular diseases
cardiovascular
diseases
Prior art date
Application number
BR1101039-8A
Other languages
English (en)
Inventor
Paolo Chiesi
Yoshiuki Inada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1101039A publication Critical patent/BR1101039A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR1101039-8A 1995-05-09 1997-05-14 Composição farmacêutica para doenças renais ou cardiovasculares BR1101039A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95830186 1995-05-09

Publications (1)

Publication Number Publication Date
BR1101039A true BR1101039A (pt) 2002-04-02

Family

ID=8221919

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1101039-8A BR1101039A (pt) 1995-05-09 1997-05-14 Composição farmacêutica para doenças renais ou cardiovasculares

Country Status (4)

Country Link
BR (1) BR1101039A (pt)
ES (1) ES2119682B1 (pt)
FR (1) FR2733911B1 (pt)
IT (1) IT1285093B1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990087076A (ko) * 1996-04-05 1999-12-15 다께다 구니오 안지오텐신 ⅱ 및 길항 활성을 갖는 화합물을 함유하는 약제학적 배합물
IT1398168B1 (it) * 2010-02-16 2013-02-14 Chiesi Farma Spa Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569789B2 (en) * 1984-05-03 1988-02-18 Brigham And Women's Hospital A.c.e. inhibitors to treat renal diseases
EP0259838A3 (en) * 1986-09-09 1989-11-15 Syntex (U.S.A.) Inc. Pharmaceutical composition containing a 1,4-dihydropyridine derivative and an acylated 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
HU199681B (en) * 1986-11-03 1990-03-28 Sandoz Ag Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition
TW197945B (pt) * 1990-11-27 1993-01-11 Hoechst Ag
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
JPH06172220A (ja) * 1992-12-03 1994-06-21 Upjohn Co:The 虚血性疾患治療用医薬組成物
DE4308504A1 (de) * 1993-03-18 1994-09-22 Knoll Ag Neue Verwendung einer Kombination aus Verapamil und Trandolapril

Also Published As

Publication number Publication date
FR2733911B1 (fr) 1998-05-29
FR2733911A1 (fr) 1996-11-15
ES2119682B1 (es) 1999-07-01
IT1285093B1 (it) 1998-06-03
ES2119682A1 (es) 1998-10-01
ITTO960379A0 (it) 1996-05-08
ITTO960379A1 (it) 1997-11-08

Similar Documents

Publication Publication Date Title
NO20004345D0 (no) Farmasøytisk sammensetning
IS4706A (is) Lyfjasamsetningar
FI973518A (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
NO973612L (no) Nytt farmasöytisk preparat
FR2751540B1 (fr) Composition pharmaceutique antithrombotique
BR9610214A (pt) Compostos farmacéuticos
LV11727A (lv) Farmaceitiska kompozicija
BR9507768A (pt) Composição farmacêutica
NO973610D0 (no) Nytt farmasöytisk preparat
MA26531A1 (fr) Composition pharmaceutique
ID18698A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
NO973611D0 (no) Nytt farmasöytisk preparat
NO950950D0 (no) Farmasöytisk preparat
BR1101039A (pt) Composição farmacêutica para doenças renais ou cardiovasculares
ITMI962628A0 (it) Composizione farmaceutica
NO965448D0 (no) Farmasöytiske forbindelser
BR9605777A (pt) Composição farmacêutica
FI962738A0 (fi) Farmaseuttiset koostumukset
NO964309D0 (no) Farmasöytisk sammensetning
SE9402924D0 (sv) Novel pharmaceutical composition
KR960016881A (ko) 제약 조성물
SE9402437D0 (sv) Pharmaceutical composition
SE9604299D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
NB Patent issued - articles 230 and 231 of law 9279/96
B25D Requested change of name of applicant approved

Owner name: CHIESI FARMACEUTICI S.P.A. (IT) , TAKEDA PHARMACEU

Free format text: NOME ALTERADO DE: TAKEDA CHEMICAL INDUSTRIES, LTD.